Ipsen falls heavily on the stock market after stopping clinical trials

Ipsen falls heavily on the stock market after stopping clinical trials

PARIS, January 24 (Reuters) – Ipsen suffers the worst drop in its stock market history Friday after the announcement of the end of clinical trials of an experimental treatment for a rare bone disease, a new setback for the product portfolio in development of the biopharmaceutical group. The Ipsen share lost 21.41% to 65.70 euros … Read more

Paris: falls below 6,000 under the weight of Renault and luxury

Paris: falls below 6,000 under the weight of Renault and luxury

(CercleFinance.com) – The Paris Stock Exchange (-0.65%) failed to raise the bar and finished below 6.000Pts, for the first of the year. The CAC40 (5.972) only made a brief foray into positive territory this Thursday noon (around 6.025) before increasing inexorably during the last 2 hours of quotations. The session was marked by the plunge … Read more

Vaccine biotechs leap to Wall Street

Vaccine biotechs leap to Wall Street

In response to the spread of the mysterious virus from Wuhan, several biotech companies say they are working on a vaccine. Through Le Figaro with AFP –Already called upon in the past to deal with SARS and Ebola, some of these laboratories saw their actions suddenly gain value this week. StockAdobe Biotech company stocks jumped … Read more

Update on recommendations changes in Paris: Renault, Sodexo, Elior …

Update on recommendations changes in Paris: Renault, Sodexo, Elior …

PARIS, January 23 (Reuters) – Main changes to recommendations and / or course objectives recorded Thursday in Paris. * RENAULT – Citigroup lowers its recommendation to “sell” against “neutral” and its target price to 30 euros against 52 euros. Barclays lowers its target price to 45 euros against 59 euros. * SODEXO – HSBC begins … Read more

Investigation into the twists and turns of the Carlos Ghosn case

Investigation into the twists and turns of the Carlos Ghosn case

WIDE ANGLE – Prior to his escape, the ex-CEO of Renault-Nissan was indicted four times in Japan. What are the charges, and how does he defend himself? –At a press conference in Beirut on January 9, Carlos Ghosn released documents in support of his defense. NABIL MOUNZER / EPA / MAXPPP This is a sprawling … Read more

Oil prices: what to expect in 2020?

Oil prices: what to expect in 2020?

After crossing the $ 70 a barrel mark at the start of the year due to escalating tensions between Washington and Tehran, raising fears of a lasting surge in prices, oil prices have stagnated in recent days at $ 65 a barrel. In short, the scenario of a possible oil shock, that is to say … Read more

The Arnault and Bettencourt Meyers families, first shareholders of the CAC 40

The Arnault and Bettencourt Meyers families, first shareholders of the CAC 40

The heirs of the founder of L’Oréal weigh more than the shareholder state. –The Paris Stock Exchange hosts a larger share of family shareholders. 12209318 / Richard Villalon – stock.adobe.com The family is a value that rises on the Paris Stock Exchange. The share of family shareholders in the CAC 40 climbed to 14.5% at … Read more

On Wall Street, indices affected by information on tariffs

On Wall Street, indices affected by information on tariffs

Wall Street indices suddenly fell back Tuesday during a session after an article by the Bloomberg agency saying that the US administration would probably leave in place the current tariffs on Chinese goods until the presidential election. The Dow Jones Industrial Average, which had been moving quietly in the green since the first part of … Read more

Update on changes to recommendations in Paris: Danone, Vivendi, Kering …

Update on changes to recommendations in Paris: Danone, Vivendi, Kering …

PARIS, January 14 (Reuters) – Main changes in recommendations and / or course objectives recorded Tuesday in Paris: DANONE – Societe Generale lowers its recommendation to “sell” against “buy” and reduces its target price to 69 euros against 82 euros, highlighting “hot spots of disappointment” in terms of organic growth. The title lost 1.19% to … Read more

GSK: authorization request in Europe for HIV-1

GSK: authorization request in Europe for HIV-1

(CercleFinance.com) – GSK announces that its subsidiary specialized in HIV, ViiV Healthcare, has submitted a request for marketing authorization to the European Medicines Agency for fostemsavir, drug candidate for the treatment of HIV infection- 1. In this application, the product is proposed in combination with other anti-retro-virals to treat adult patients for whom it is … Read more